Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quercetin for thalassemia-induced depression
IRCT20091114002709N46Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Apr 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of quercetin in major depressive disorder (MDD) and beta thalassemia major, sponsored by Iran University of Medical Sciences. Started Apr 2017; status: completed.
02
Drugs
quercetin
03
Conditions
major depressive disorder (MDD)beta thalassemia major
Beyond the preview
Go deeper on IRCT20091114002709N46.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20091114002709N46.